Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Alkermes bolts on Rodin Therapeutics to bulk up thin pipelin...

Merck builds in CNS diseases with $576m Calporta buy

Allergan pays $750m to avoid Alzheimer’s drug lawsuit

Surprise! Biogen says Alzheimer’s drug works after all and w...

Last BACE bombs: Eisai, Biogen give up on elenbecestat